Cargando…
Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response
Ferritin heavy chain (FTH1) is a 21-kDa subunit of the ferritin complex, known for its role in iron metabolism, and which has recently been identified as a favorable prognostic protein for triple negative breast cancer (TNBC) patients. Currently, it is not well understood how FTH1 contributes to an...
Autores principales: | Liu, Ning Qing, De Marchi, Tommaso, Timmermans, Annemieke M., Beekhof, Robin, Trapman-Jansen, Anita M.A.C., Foekens, Renée, Look, Maxime P., van Deurzen, Carolien H. M., Span, Paul N., Sweep, Fred C.G.J., Brask, Julie Benedicte, Timmermans-Wielenga, Vera, Debets, Reno, Martens, John W. M., Foekens, John A., Umar, Arzu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083117/ https://www.ncbi.nlm.nih.gov/pubmed/24742827 http://dx.doi.org/10.1074/mcp.M113.037176 |
Ejemplares similares
-
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
por: Liu, Ning Qing, et al.
Publicado: (2016) -
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015) -
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2017) -
4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015) -
HER2-low breast cancer shows a lower immune response compared to HER2-negative cases
por: van den Ende, Nadine S., et al.
Publicado: (2022)